Cargando…

Anti-Cancer Effect of HIV-1 Viral Protein R on Doxorubicin Resistant Neuroblastoma

Several unique biological features of HIV-1 Vpr make it a potentially powerful agent for anti-cancer therapy. First, Vpr inhibits cell proliferation by induction of cell cycle G2 arrest. Second, it induces apoptosis through multiple mechanisms, which could be significant as it may be able to overcom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Richard Y., Liang, Dong, Li, Ge, Larrimore, Christopher W., Mirkin, Bernard L.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2898807/ https://www.ncbi.nlm.nih.gov/pubmed/20628645 http://dx.doi.org/10.1371/journal.pone.0011466

Ejemplares similares

The Effect of Vorinostat on the Development of Resistance to Doxorubicin in Neuroblastoma
por: Lautz, Timothy B., et al.
Publicado: (2012)

Cell cycle G2/M arrest through an S phase-dependent mechanism by HIV-1 viral protein R
por: Li, Ge, et al.
Publicado: (2010)

Non-viral nitric oxide-based gene therapy improves perfusion and liposomal doxorubicin sonopermeation in neuroblastoma models
por: Bellary, Aditi, et al.
Publicado: (2023)

Panobinostat Synergistically Enhances the Cytotoxic Effects of Cisplatin, Doxorubicin or Etoposide on High-Risk Neuroblastoma Cells
por: Wang, Guan, et al.
Publicado: (2013)

Doxorubicin-Induced TrkAIII Activation: A Selection Mechanism for Resistant Dormant Neuroblastoma Cells
por: Cappabianca, Lucia, et al.
Publicado: (2022)

Time-dependent simvastatin administration enhances doxorubicin toxicity in neuroblastoma
por: Anderson, Colin C., et al.
Publicado: (2020)

The comparison of cytotoxicity of the anticancer drugs doxorubicin and ellipticine to human neuroblastoma cells
por: Poljaková, Jitka, et al.
Publicado: (2008)

Novel proteasome inhibitor ixazomib sensitizes neuroblastoma cells to doxorubicin treatment
por: Li, Haoyu, et al.
Publicado: (2016)

Sindbis viral structural protein cytotoxicity on human neuroblastoma cells
por: Saito, Eriko Y., et al.
Publicado: (2020)

Simultaneous delivery of anti-miR21 with doxorubicin prodrug by mimetic lipoprotein nanoparticles for synergistic effect against drug resistance in cancer cells
por: Rui, Mengjie, et al.
Publicado: (2016)

Doxorubicin-provoked increase of mitotic activity and concomitant drain of G0-pool in therapy-resistant BE(2)-C neuroblastoma
por: Hultman, Isabell, et al.
Publicado: (2018)

Anti-GRP-R monoclonal antibody antitumor therapy against neuroblastoma
por: Qiao, Jingbo, et al.
Publicado: (2022)

A Rare Case of Breast Implant-Associated Diffuse Large B-Cell Lymphoma
por: Larrimore, Christopher, et al.
Publicado: (2019)

Combination therapy with gefitinib and doxorubicin inhibits tumor growth in transgenic mice with adrenal neuroblastoma
por: Kawano, Kumi, et al.
Publicado: (2013)

Graphene Oxide Functional Nanohybrids with Magnetic Nanoparticles for Improved Vectorization of Doxorubicin to Neuroblastoma Cells
por: Lerra, Luigi, et al.
Publicado: (2018)

Second-generation proteasome inhibitor carfilzomib sensitizes neuroblastoma cells to doxorubicin-induced apoptosis
por: Guan, Shan, et al.
Publicado: (2016)

Modulation of doxorubicin resistance in a doxorubicin-resistant human leukaemia cell by an immunoliposome targeting transferring receptor.
por: Suzuki, S., et al.
Publicado: (1997)

HIV-1 resists MxB inhibition of viral Rev protein
por: Wang, Zhen, et al.
Publicado: (2020)

Differential effect of long-term drug selection with doxorubicin and vorinostat on neuroblastoma cells with cancer stem cell characteristics
por: Zheng, X, et al.
Publicado: (2013)

Curcumin reverses doxorubicin resistance via inhibition the efflux function of ABCB4 in doxorubicin-resistant breast cancer cells
por: Wen, Chunjie, et al.
Publicado: (2019)

Tissue factor/FVIIa activates Bcl-2 and prevents doxorubicin-induced apoptosis in neuroblastoma cells
por: Fang, Jun, et al.
Publicado: (2008)

Doxorubicin treatment induces tumor cell death followed by immunomodulation in a murine neuroblastoma model
por: INOUE, SEIICHIRO, et al.
Publicado: (2014)

In vivo anti-tumour activity of FCE 23762, a methoxymorpholinyl derivative of doxorubicin active on doxorubicin-resistant tumour cells.
por: Ripamonti, M., et al.
Publicado: (1992)

Involvement of miR-30c in resistance to doxorubicin by regulating YWHAZ in breast cancer cells
por: Fang, Y., et al.
Publicado: (2014)

Anti-drug resistance, anti-inflammation, and anti-proliferation activities mediated by melatonin in doxorubicin-resistant hepatocellular carcinoma: in vitro investigations
por: Hamed, Ahmed R., et al.
Publicado: (2023)

The impact of At1r inhibition via losartan on the anti-leukaemic effects of doxorubicin in acute myeloid leukaemia
por: Ghasemi, Mehdi, et al.
Publicado: (2019)

Artemether Regulates Chemosensitivity to Doxorubicin via Regulation of B7-H3 in Human Neuroblastoma Cells
por: Tan, Wei-Qiang, et al.
Publicado: (2017)

Perfusion-guided sonopermeation of neuroblastoma: a novel strategy for monitoring and predicting liposomal doxorubicin uptake in vivo
por: Bellary, Aditi, et al.
Publicado: (2020)

Doxorubicin and resveratrol co-delivery nanoparticle to overcome doxorubicin resistance
por: Zhao, Yuan, et al.
Publicado: (2016)

miR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1
por: Gao, Man, et al.
Publicado: (2016)

Modulation of multidrug resistance proteins by statins in human neuroblastoma
por: Sieczkowski, Evelyn, et al.
Publicado: (2008)

MiR-155 Negatively Regulates Anti-Viral Innate Responses among HIV-Infected Progressors
por: Pawar, Puja, et al.
Publicado: (2023)

Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells
por: Wang, Xu, et al.
Publicado: (2019)

Knockdown of astrocyte elevated gene-1 inhibits proliferation and enhancing chemo-sensitivity to cisplatin or doxorubicin in neuroblastoma cells
por: Liu, Haiyan, et al.
Publicado: (2009)

Surgery combined with controlled-release doxorubicin silk films as a treatment strategy in an orthotopic neuroblastoma mouse model
por: Chiu, B, et al.
Publicado: (2014)

Inhibition of cathepsin proteases attenuates migration and sensitizes aggressive N-Myc amplified human neuroblastoma cells to doxorubicin
por: Gangoda, Lahiru, et al.
Publicado: (2015)

miR-181c expression in neuroblastoma children and proliferation of neuroblastoma M17 cells
por: Xu, Xueyan, et al.
Publicado: (2019)

Protein binding of 4-hydroxybenzoic acid and 4-hydroxy-3-methoxybenzoic acid to human serum albumin and their anti-proliferation on doxorubicin-sensitive and doxorubicin-resistant leukemia cells
por: Myint, Ohnmar, et al.
Publicado: (2021)

Anti-cancer effects of Rhizoma Curcumae against doxorubicin-resistant breast cancer cells
por: Zhong, Zhangfeng, et al.
Publicado: (2018)

Downregulation of HuR as a new mechanism of doxorubicin resistance in breast cancer cells
por: Latorre, Elisa, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_n7lr39u7o9nb3q1jlhv34e9n0d